Clinical Trials in Pittsburgh

Showing 1141-1160 of 18,076 trials

Creating Peace: Community-based Youth Violence Prevention to Address Racism and Discrimination

NCT04474158

This cluster-randomized community-partnered study will examine the effectiveness of a trauma-sensitive, gender transformative youth violence prevention program called Creating Peace that integrates racism and discrimination prevention with youth ages 14-19.

Adolescent BehaviorGroup, PeerViolence, Non-accidental+5 more

University of Pittsburgh581 participantsStarted Dec 2020

Pittsburgh, Pennsylvania, United States

Active Not RecruitingPhase 256 miles

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

NCT04488081

The goal of this project is to rapidly screen promising agents, in the setting of an adaptive platform trial, for treatment of critically ill COVID-19 patients. In this phase 2 platform design, agents will be identified with a signal suggesting a big impact on reducing mortality and the need for, as well as duration, of mechanical ventilation.

COVID-19

QuantumLeap Healthcare Collaborative1,500 participantsStarted Jul 2020

Birmingham, Alabama, United States • Davis, California, United States • Irvine, California, United States +33 more locations

Creating Peace: Community-based Youth Violence Prevention to Address Racism and Discrimination

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Find Trials by Condition in Pittsburgh

An International Observational Study of Adults With Acute Infection

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

Regeneration of Acutely Injured Nerves With Temporary Electrical Stimulation

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

Premedication to Reduce Amivantamab Associated Infusion Related Reactions

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

Study of VYD2311 for the Prevention of COVID-19

ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)

A Study to Evaluate the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI) and Major Adverse Kidney Events (MAKE)

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer